News

“This is the golden age of neuro right now and we’re smack dab in the middle of it,” said Greg Alden, DBC’s President and CEO, in a recent interview with the Maryland Department of Commerce. They discussed:

GLEN BURNIE // February 20, 2024 - Dr. Michael Long recently had an interview with BioTechniques to discuss his research and how DBC gives him the tools he needs to succeed.

GLEN BURNIE // February 16, 2024 - Founder and CTO, Brian Jamieson, shares his thoughts on the potential of brain-computer interfaces. He sheds light on the history of BCIs, but notes that common use amongst larger populations remains unknown in the coming years.

GLEN BURNIE // February 1, 2024 - Brian Jamieson, the founder and CTO of DBC, discusses the company's approach to neural interfacing technology, its impact on brain research, and what lies ahead in the realm of neuroscience in our latest interview.

GLEN BURNIE // January 31, 2024 - Founder and CTO, Brian Jamieson, shares his thoughts on the potential of brain-computer interfaces.

GLEN BURNIE // December 27, 2023 - Forbesrecently sat down with Greg Alden, CEO and President of Diagnostic Biochips, to discuss his career, how he brings his unique perspective as a Parkinson’s patient to DBC’s work, and the latest on the treatment horizon for neurodegenerative diseases.

GLEN BURNIE // November, 2023 - Business Monthly features Diagnostic Biochips in their November 2023 release.

GLEN BURNIE // April 7, 2024 - Diagnostic Biochips' Founder and CTO shares insights into the evolving world of brain-computer interfaces (BCIs) in an interview with BioPharmaTrend.